If you would like to ask our webinar guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPci-pal Regulatory News (PCIP)

Share Price Information for Pci-pal (PCIP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 61.00
Bid: 60.00
Ask: 62.00
Change: 0.00 (0.00%)
Spread: 2.00 (3.333%)
Open: 61.00
High: 61.00
Low: 61.00
Prev. Close: 61.00
PCIP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Changes

29 Aug 2014 10:49

RNS Number : 3544Q
IPPlus PLC
29 August 2014
 

For immediate release

29 August 2014

IPPLUS PLC

("IPPLUS" or the "Company")

Directorate Changes

IPPlus PLC today announces the appointment of Chris Fielding, as a Non-Executive Director, with immediate effect.

Mr. Christopher Michael Fielding (aged 55) is currently Head of Corporate Finance at W H Ireland and brings with him over thirty years' experience of corporate and financial skills. Previous to his current role, Mr. Fielding worked at Arden Partners and spent eleven years prior to that at Hoare Govett, where he was a director of Corporate Finance. He qualified as a chartered accountant with Price Waterhouse and then held appointments at Thomas Cook, Cadbury Schweppes, and Barclays de Zoete Wedd.

In accordance with Schedule 2(g) of the AIM Rules, Mr. Fielding holds or has held in the past 5 years the following directorships and partnerships:

Current

Past 5 years

None

W H Ireland Limited

Mr. Fielding does not hold any shares in the Company.

Save for the disclosures above, there are no further disclosures to be made in accordance with Rule 17 and Schedule 2(g) of the AIM Rules.

The Company also announces that after nearly four years' service Bernard Waldron has stated his intention to stand down as a Non-Executive Director, with effect from 30 September 2014. The Board wishes to express its gratitude to Mr. Waldron for his service to the Company and extends its best wishes to him in his future endeavours.

Philip Dayer, the current Chairman, has also advised the board that it is his intention to stand down at the end of 2014 having served the Company for 9 years. It is the Company's expectation that Mr. Fielding will take over the Chairman's role on Mr. Dayer's departure. A further announcement will be made in due course relating to this.

For further information, please contact:

IPPLUS PLC

Tel: +44 (0)1473 321 800

William Catchpole, Chief Executive Officer

Stuart Gordon, Chief Financial Officer

 

N+1 Singer (Nomad & Broker)

Tel: +44 (0)20 7496 3000

Aubrey Powell

Alex Wright

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAEANPNALXLEEF
Date   Source Headline
17th Apr 20245:45 pmRNSHolding(s) in Company
8th Apr 202410:28 amRNSIssue of Equity & TVR
5th Apr 20247:00 amRNSIssue of Options & Director Share Purchases
4th Apr 202410:24 amRNSIssue of Equity & TVR
28th Mar 20246:15 pmRNSHolding(s) in Company
27th Mar 20247:00 amRNSExercise of Options, Director/PCA Dealings & TVR
26th Mar 202410:57 amRNSPDMR Issue of Options
12th Mar 202412:55 pmRNSResult of Oversubscribed Placing & TVR
12th Mar 20247:00 amRNSProposed Placing to raise up to £3.5m
27th Feb 20247:00 amRNSInterim Results, Board Change & Presentations
20th Feb 20247:00 amRNSNotice of Results, Analyst & Investor Presentation
6th Feb 20247:00 amRNSTrading Update & Notice of Results
26th Jan 202412:50 pmRNSUK Patent Case Update
22nd Jan 20244:59 pmRNSHolding(s) in Company
15th Jan 202412:20 pmRNSIssue of Equity
20th Dec 20237:00 amRNSSuccessful Completion of Form of Order Hearing
19th Dec 20237:00 amRNSUK Court Hearing
12th Dec 20231:40 pmRNSResult of AGM
12th Dec 20237:00 amRNSAGM Statement
24th Nov 202310:45 amRNSAnnual Financial Report & Notice of AGM
13th Nov 20237:00 amRNSNew strategic reseller partnership with Zoom
9th Nov 20237:00 amRNSFinal Results, Analyst Briefing & Investor Pres
6th Nov 20237:00 amRNSNotice of Results Analyst Briefing & Investor Pres
5th Oct 202311:49 amRNSIssue of Equity
4th Oct 20235:13 pmRNSHolding(s) in Company
3rd Oct 20237:00 amRNSDetail on Patent Case Outcome & Trading Update
25th Sep 20235:29 pmRNSTotal Victory for PCI Pal in UK High Court
4th Sep 20237:00 amRNSHolding(s) in Company
26th Jun 202311:33 amRNSHolding(s) in Company
7th Jun 20237:00 amRNSBreach of confidentiality agreement by Sycurio Ltd
30th May 20237:00 amRNSDirector/PDMR Share Purchase
25th May 202311:08 amRNSDirector/PDMR Share Purchase
24th May 20237:00 amRNSTrading and Patent Case Updates
14th Mar 20237:00 amRNSInterim Results, Analyst Briefing & Investor Pres
13th Mar 20237:49 amRNSSVB Update
28th Feb 20237:00 amRNSNotice of Results, Analyst Call & Investor Pres
2nd Feb 20237:00 amRNSTrading Update & Notice of Results
27th Oct 202212:32 pmRNSResult of AGM
27th Oct 20227:00 amRNSAGM Statement
20th Oct 20227:00 amRNSPDMR Shareholding
7th Oct 20227:00 amRNSDirector/PDMR Issue of Options
6th Oct 20223:13 pmRNSDirector/PDMR share purchase
4th Oct 202210:37 amRNSAnnual Financial Report & Notice of AGM
22nd Sep 20227:00 amRNSPCI Pal launches open banking payments product
6th Sep 20227:00 amRNSFinal Results, Analyst Briefing & Investor Pres
16th Aug 20227:00 amRNSNotice of Results Analyst Briefing & Investor Pres
27th Jul 20227:00 amRNSTrading Update & Notice of Results
1st Jul 20227:00 amRNSDirectorate Change
30th Jun 20221:56 pmRNSIssue of Equity
28th Jun 20227:00 amRNSUpdate on Patent Infringement Claims

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.